Remdesivir The Drug That The Nurses Nicknamed “Run Death Is Near”

Remdesivir Was Declared Too Deadly & Unethical To Use In African Ebola Trials Because It Had A 53% Kill Rate.

Yet, It Was The Only Drug Fauci Allowed To Be Used On COVID Patients In Hospitals.

Remdesivir Is Still Used Today & It Is Now Being Used On Infants & Children...

The drug is so lethal it got nicknamed ‘Run Death Is Near’ after it started killing thousands of Covid patients in the hospital.

Remdesivir (Veklury) kills kidney function, combine that with a ventilator & patients develop pulmonary edema, causing their lungs to fill with fluid & drown to death.

Remdesivir kills the liver & causes organ shut down.

In the halted Ebola trial, Remdesivir mortality was 53% overall & 85% mortality in those with high viral load.

The US Govt BRIBED Hospitals to Administer a Kidney & Liver Toxic Drug with incentives & huge bonuses.

Anthony Fauci claimed that Remdesivir would stop Covid even though he knew it would cause 1000s of deaths.

Remdesivir (Veklury) never stopped Covid...instead, it stopped kidney function, then it fatally stopped the liver & heart.

What the US government never told you about Remdesivir is that by November 2020, even the World Health Organization (WHO) stated, "Do not use Remdesivir."

But instead of heading this warning, the NIH & HHS added a 20% bonus on the entire hospital if they administered this liver, kidney & heart-toxic drug.

That 20% bonus ended up being a BIG pay day.

There has never been a virus that attacks the kidneys...because it wasn't the COVID virus attacking the kidneys...it was the Remdesivir.

Remdesivir is still being used in hospitals today...and now Remdesivir (Veklury) is approved for use in infants.

Specifically, the Food & Drug Administration (FDA) expanded its approval of remdesivir to include pediatric patients 28 days of age & older.

Remdesivir (Veklury) is the ONLY approved treatment for hospitalized or non-hospitalized children that have mild-to-moderate COVID-19 & a positive PCR test.

It historically takes 6 to 10 years for a drug approved for adults to receive pediatric labeling.

Remdesivir was fast tracked & approved for use in pediatric patients, including neonates, all within 3 years of approval for use in adults & adolescents.

👇African Ebola Drug Trials Using Remdesivir👇
franciskovacevic.com/remdesivir-201…
👇Kidney Failure From Remdesivir👇
scielosp.org/article/csp/20…
👇Heart Failure From Remdesivir👇
pmc.ncbi.nlm.nih.gov/articles/PMC85…
👇Liver Failure From Remdesivir👇
pmc.ncbi.nlm.nih.gov/articles/PMC82…

Speaker: Dr Bryan Ardis